Director, Investor Relations

Jade BiosciencesSan Francisco, CA
Remote

About The Position

Jade Biosciences is seeking a Director, Investor Relations to help build and execute a high caliber investor relations function for a publicly traded biotechnology company. The Director will play a central role in communicating Jade’s strategy, pipeline, scientific rationale, clinical development progress, financial position, and value proposition to a primarily investor audience, including institutional investors, sell-side analysts, bankers, and other capital markets stakeholders. This role requires a strong understanding of biotechnology equity markets, clinical-stage company strategy, and investor-facing communications. The ideal candidate will be able to translate complex scientific, clinical, regulatory, and financial information into clear, credible, and compelling messaging for sophisticated external audiences. Former sell-side biotechnology research professionals are encouraged to apply, including candidates who served as research associates supporting biotechnology or healthcare coverage. This is a remote role reporting to the Chief Financial Officer and will require periodic travel for investor conferences, investor roadshows, medical and scientific meetings, company meetings, and Board or leadership events.

Requirements

  • Bachelor’s degree ; advanced degree in a scientific, medical, business, finance, or related field preferred.
  • At least 10 years of related experience with 5 to 8+ years of relevant experience in biotechnology investor relations, sell-side equity research, investment banking, corporate strategy, business development, corporate communications, or a related capital markets role.
  • Prior experience as a sell-side biotechnology or healthcare research associate, or comparable experience developing public equity research, investor materials, or clinical-stage company analysis, is highly valued.
  • Strong understanding of public biotechnology company dynamics, including clinical development milestones, regulatory pathways, financing strategy, investor expectations, peer benchmarking, and disclosure considerations.
  • Ability to communicate sophisticated scientific and clinical concepts clearly to institutional investors and analysts, while maintaining scientific accuracy and appropriate caveats .
  • Excellent written and verbal communication skills, with demonstrated ability to create polished investor-facing materials, briefing documents, Q&A, and executive talking points.
  • High attention to detail, strong judgment, discretion with confidential information, and comfort operating in a fast-paced public company environment.
  • Strong analytical skills, including ability to interpret clinical data, financial information, ownership data, analyst reports, and market feedback.
  • Collaborative, proactive, and low-ego working style with the ability to partner effectively across scientific, clinical, finance, legal, and executive functions.
  • Familiarity with Regulation FD and public company disclosure practices preferred.
  • Proficiency with Microsoft PowerPoint, Excel, Word, investor databases, and market intelligence tools; familiarity with FactSet, CapIQ , Bloomberg, Visible Alpha, Ipreo , AlphaSense , or similar platforms is a plus.
  • Willingness to travel periodically for investor conferences, roadshows, company meetings, and other business needs.

Responsibilities

  • Support the development and execution of Jade’s investor relations strategy in partnership with the CFO, CEO, and senior leadership team.
  • Develop and refine investor messaging, Q&A, presentation materials, SEC filings, earnings or corporate update materials, investor conference materials, and other external communications.
  • Serve as a key point of contact for investors and sell-side analysts, helping ensure timely , accurate , consistent, and Regulation FD-compliant communications.
  • Translate complex scientific, clinical, regulatory, competitive, and financial information into clear investor-facing narratives tailored to public market audiences.
  • Monitor investor sentiment, analyst commentary, trading dynamics, peer company disclosures, competitive developments, sector trends, and relevant clinical or regulatory catalysts.
  • Prepare briefing materials for executive leadership ahead of investor meetings, conferences, roadshows, analyst calls, and other external engagements.
  • Help maintain and enhance the company’s investor materials, including the corporate presentation, investor website content, fact sheets, event calendars, and FAQ documents.
  • Partner cross- functionally with Finance, Legal, Clinical Development, Regulatory, Medical, Corporate Communications, and external advisors to ensure alignment of investor communications.
  • Assist with quarterly reporting processes, including call preparation, scripts, press releases, Q&A preparation, and post-call investor feedback synthesis.
  • Support capital markets activities, investor targeting, ownership analysis, conference strategy, and engagement planning in partnership with external IR, banking, and legal advisors, as appropriate .
  • Develop concise summaries of investor feedback, market perception , and emerging questions for the leadership team and Board of Directors.
  • Maintain strong command of Jade’s programs, target indications, competitive landscape, upcoming milestones, and key investor diligence topics.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service